This HTML5 document contains 62 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1056/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57605349
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2011 наукова стаття, опублікована в березні 2011 wetenschappelijk artikel im März 2011 veröffentlichter wissenschaftlicher Artikel article by Hermann Haller et al published 10 March 2011 in The New England Journal of Medicine
p:P577
wds:Q57605349-36BFD39D-CF23-47B0-80BC-4453BBCA951F
wdt:P577
2011-03-10T00:00:00Z
p:P407
wds:Q57605349-77D19646-8F5B-42AC-BDE7-A8B8B6764D59
wdt:P407
wd:Q1860
p:P2093
wds:Q57605349-2BC1197C-9EE3-4A2F-A337-8AC1C6D1FA98 wds:Q57605349-7F4C0E09-3357-4F42-91C4-958B4F71358D wds:Q57605349-8AF8F65B-99D7-48FC-BF81-14E043FBD1A9 wds:Q57605349-CCA5A96D-D498-4EF4-940A-D6777E7B0B03 wds:Q57605349-D77AC0DD-9662-4DF4-AFFC-103F4DBCE926 wds:Q57605349-C1D78C6C-3B3E-4CA2-B4A9-01B709B07C48 wds:Q57605349-F821AB93-9247-4CD4-A874-4950DD004A54 wds:Q57605349-09BA7FED-FC9F-4F9B-B33A-A1BBBD8A6C96
wdt:P2093
Lars C. Rump Shigehiro Katayama Giancarlo Viberti Albert Mimran Eberhard Ritz Joseph L. Izzo Jan Menne Ton J. Rabelink
rdfs:label
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
skos:prefLabel
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
schema:name
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
p:P50
wds:Q57605349-9BDC09B8-F15A-4A40-8394-5268BEF55FEC wds:Q57605349-A8FA1586-00A7-4D14-A7B6-4960A75B218D wds:Q57605349-0735F6EB-6937-435F-A535-A782E76EDD03 wds:Q57605349-F2D51581-3C8A-4F27-BACC-A61336D018B5 wds:Q57605349-580DDA83-92C4-42EF-B47A-EA86AD458496
wdt:P50
wd:Q58432162 wd:Q56550076 wd:Q30932255 wd:Q56955546 wd:Q16528666
p:P1476
wds:Q57605349-3C524E20-BB0A-4B0C-9B84-7BFE2A8C1896
wdt:P1476
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
p:P304
wds:Q57605349-04DF4F0E-D91F-4296-BA00-B46414BA3AD6
wdt:P304
907-917
p:P31
wds:Q57605349-0685540C-2A18-4E11-9DEC-598DB21B98A6
wdt:P31
wd:Q13442814
p:P921
wds:Q57605349-4FCE31D2-A16D-48BB-AA2E-00E20ECBD70A
wdt:P921
wd:Q3025883
p:P698
wds:Q57605349-E7C4836B-4378-4638-96E4-7DB830D5DD89
wdtn:P698
n11:21388309
wdt:P698
21388309
p:P1433
wds:Q57605349-F9398209-2F36-4F73-9B65-A381AA6F295D
wdt:P1433
wd:Q582728
p:P433
wds:Q57605349-AE747F80-737D-48D3-8570-D941B8267ACF
p:P478
wds:Q57605349-0F9C622D-8B6D-4C66-9A6B-B0AF5B13834F
wdt:P433
10
wdt:P478
364
p:P356
wds:Q57605349-C18E6AC0-1A26-46C7-9FE7-99C5EAE522BC
wdtn:P356
n10:NEJMOA1007994
wdt:P356
10.1056/NEJMOA1007994